SBA Loans for Dental Practice Acquisition in 2026: Rates, DSCR & the 60–75 Day Close

The SBA 7(a) loan is the standard financing vehicle for dental practice acquisitions because it's one of the only loan structures that lends against goodwill and cash flow rather than hard collateral — and most of a dental practice's purchase price is goodwill. A typical general practice selling for $850K might carry only $150K–$250K in tangible assets (chairs, imaging, cabinetry, supplies); the remaining 70–80% of the price is the patient base, recall schedule, payer contracts, and reputation. Conventional bank loans struggle with that asset mix. The 7(a) program was built for it.

The structural advantages line up almost perfectly with how practice sales work. A 7(a) acquisition loan runs 10 years for a practice purchase (up to 25 years when real estate is included), which spreads debt service thin enough that the practice's existing cash flow covers the payment from day one. Rates in July 2026 are typically Prime-based and land in the 10–13% APR range at most lenders — dental deals with strong collections and an experienced buyer often price toward the bottom of that band, though final pricing is always lender- and deal-specific. Down payments start at 10% of the project cost, versus the 20–30% a conventional lender would want on a goodwill-heavy purchase.

Dentists are also, bluntly, a favored borrower class. Practice default rates in dentistry run among the lowest of any industry in the SBA portfolio, which is why a meaningful number of SBA lenders run dedicated dental or healthcare desks. That competition matters: the difference between a generalist SBA lender and a dental-specialized Preferred Lender can be 30–45 days of timeline and a full point of rate. Bay Street Lending places acquisition deals across SBA lenders — including dental-book PLPs — off a single application and soft credit pull.

The Four Acquisition Scenarios 7(a) Covers

The same loan structure handles the four ways dental practices change hands: a retiring-dentist sale (full 100% purchase, seller typically stays 30–90 days for transition), an associate buy-in (partial equity purchase, often 25–50% of the practice, financed as a partner buy-in under the 2023+ SBA rules that allow partial ownership changes), a partner buyout (one owner acquiring the other's stake), and a DSO exit (a dentist buying a location back from — or out from under — a dental service organization, usually priced off location-level EBITDA). Each scenario is underwritten on the same core question: does the practice's cash flow cover the new debt with room to spare?

An SBA loan for a dental practice acquisition is underwritten differently than a standard business loan — the lender is primarily qualifying the practice being purchased, not a business you already own. The practice needs an operating track record (2+ years is the practical floor, and most sellable practices have decades); the buyer needs a dental license, credit, and enough industry experience to convince the lender the patient base will stay.

The 2026 checklist most dental SBA lenders work from:

• Buyer credit: 680+ FICO is the working threshold; 700+ prices better. One or two aged blemishes with a written explanation rarely kill a dental deal.
• Buyer experience: 2+ years of clinical production as an associate is the informal standard. Lenders want to see personal production numbers ($60K–$100K+/month in collections attributable to you) proving you can maintain the practice's revenue after the seller leaves.
• Practice financials: 3 years of tax returns and P&Ls, current-year interims, and production-by-provider reports. Target practices generally need $150K+ in annual revenue to clear SBA underwriting — real acquisition candidates are usually $600K–$2M+ in collections.
• Debt service coverage: 1.25 DSCR minimum on the post-acquisition cash flow (covered in detail below).
• Equity injection: 10% of total project cost, with seller standby notes able to cover a portion (also below).
• Personal guarantee: required from any 20%+ owner, standard across all 7(a) lending.

Note what's not on the list: heavy personal collateral. The 7(a) program requires lenders to take available collateral but does not decline loans for lack of it — a buyer with a mortgage and no other assets can still close a $1M practice acquisition. For the full program-level breakdown beyond acquisitions, see our SBA loan requirements guide.

Preferred Lenders (PLPs) Close 60–75 Days; Generalists Take 90–120

The single biggest controllable variable in an SBA acquisition timeline is which lender holds the file. SBA Preferred Lenders (PLPs) have delegated authority to approve loans in-house without sending the file to the SBA for sign-off — that alone removes 2–4 weeks. PLPs that run dedicated dental books compound the advantage: their underwriters already know what a healthy hygiene ratio looks like, don't stumble on payer-mix questions, and have practice-valuation reviewers on staff. A dental-specialized PLP routinely closes acquisitions in 60–75 days from complete application; a generalist bank running the same file through standard SBA processing typically needs 90–120 days. When a seller has three offers and a retirement date, that difference decides who buys the practice. Comparing SBA lenders through a broker is the fastest way to land the file on a dental-experienced PLP desk instead of a general commercial queue.

Dental practice pricing runs on two parallel yardsticks, and your lender will check the purchase price against both. The first is percentage of annual collections: general practices in most markets trade at roughly 60–85% of trailing-12-month collections, with well-run practices in strong metros pushing higher and rural or declining practices pricing lower. The second is an EBITDA multiple: solo and small-group general practices commonly trade around 3–5× adjusted EBITDA, while multi-location groups and specialty practices (ortho, oral surgery, endo) with DSO buyer interest can command 5–7×+. Both ranges are genuinely market-dependent — a practice's payer mix, facility lease terms, and provider dependence move the number materially, which is why SBA lenders require an independent third-party valuation on every acquisition.

Here's how those norms map to typical deal structures at three common practice sizes:

Practice profile	Annual collections	Typical price range	SBA 7(a) loan	Buyer cash at 10% equity*
Solo GP, 3–4 ops	$650K–$900K	$450K–$750K	$400K–$700K	$25K–$75K
Established GP, 5–7 ops, associate	$1.2M–$1.8M	$850K–$1.5M	$800K–$1.4M	$45K–$150K
Group / specialty practice	$2M–$4M+	$1.6M–$3.5M+	$1.5M–$3.2M	$80K–$350K

*Assumes a seller standby note covers part of the 10% injection where the lender allows it — see the equity section below. Project cost also includes working capital reserves and closing costs on top of the purchase price.

Two pricing traps worth flagging. First, collections vs. production: valuations key off collections (cash actually received), not gross production. A practice producing $1.4M but collecting $1.1M against heavy PPO write-offs is a $1.1M-collections practice for both valuation and lending purposes. Second, seller-dependent revenue: if the selling dentist personally produces 85%+ of collections and works a specialty procedure mix the buyer can't replicate, expect both the valuer and the underwriter to haircut the sustainable-revenue assumption — and the loan amount with it.

Two numbers decide whether a dental acquisition gets approved: the debt service coverage ratio and the equity injection. Everything else in underwriting feeds one of these two.

How the 1.25 DSCR Works on a Practice Purchase

SBA lenders require the practice's cash flow to cover the new loan payment by at least 1.25×. The math runs on adjusted cash flow: the practice's EBITDA, plus the seller's discretionary add-backs (personal auto, above-market seller compensation, one-time expenses), minus a replacement salary for the buyer — because you have to pay yourself a livable dentist's wage before the lender counts a dollar toward debt service. A worked example: a practice with $1.2M in collections generating $340K in adjusted cash flow, minus a $180K buyer salary, leaves $160K available for debt service. At 1.25 DSCR, that supports roughly $128K/year in payments — which at ~11% over 10 years carries a loan in the neighborhood of $780K. If the purchase price plus working capital pushes the loan above what the DSCR supports, the deal gets restructured: lower price, bigger equity injection, or a seller note on standby.

The 10% Equity Injection — and How Seller Notes Cover Part of It

The SBA requires the buyer to inject 10% of total project cost on a complete change of ownership. On a $1M project that's $100K — real money for an associate a few years out of school. The pressure valve is the seller standby note: under current SOP rules, seller financing can count toward up to half of the required injection (so 5% of the 10%) provided the note sits on full standby — no principal or interest payments — for the life of the SBA loan. A motivated retiring seller carrying a $50K standby note cuts the buyer's cash requirement to $50K on that $1M deal, and sellers agree to it constantly because it signals confidence in the practice and gets their deal closed. Structure matters: a seller note with payments starting in year three does not count toward equity and instead gets added to the DSCR calculation as debt. Get the standby language right before the purchase agreement is signed — an SBA financing team that works acquisition deals weekly will catch this in the term-sheet stage, not at closing.

Buyer-side sources for the remaining injection are flexible: personal savings, gifted funds (with a gift letter), home equity, and in some structures retirement rollovers. What can't fund the injection is borrowed money that shows up as a new personal liability — lenders trace the source of every injection dollar over the prior 60–90 days of personal statements.

Dental acquisition underwriting goes several layers deeper than tax returns. The lender is trying to answer one question — will the patients and the revenue survive the ownership change? — and five artifacts carry most of the weight:

• Production-by-provider reports. The single most scrutinized document. Underwriters split collections between the selling doctor, associates, and hygiene. A practice where associates and hygiene generate 50%+ of production transfers cleanly; one where the seller personally produces nearly everything is a revenue-retention risk priced accordingly.
• Payer mix. Fee-for-service and PPO-heavy practices underwrite at face value. A practice with 40%+ Medicaid revenue gets extra questions about reimbursement-rate risk and whether the buyer will be credentialed on the same plans at close — credentialing gaps of 60–90 days can crater the first quarter's collections.
• Hygiene revenue percentage. Healthy general practices run 25–33% of collections through hygiene. Strong hygiene numbers signal a real recall program and recurring-revenue durability that doesn't depend on any one doctor's hands. Below ~20%, underwriters ask whether the recall system is broken.
• Staff retention plan. Patients are loyal to hygienists and front-desk staff as much as to the doctor. Lenders want to see key staff staying post-close — some ask for it in writing. A pending office-manager departure is a legitimate underwriting issue.
• Seller transition terms. A 30–90 day post-close transition (seller introduces the buyer, works a reduced schedule, letters go out to the patient base) is standard and lenders want it documented in the purchase agreement. Longer transitions (6–12 months of the seller working back part-time) are common in larger practices and read as risk mitigation.

Assemble these before the lender asks. A complete dental file — three years of practice financials, production reports, payer breakdown, buyer's personal financial statement and production history, purchase agreement with transition and standby terms — is the difference between a 60-day close and a 100-day close, because most SBA delay is document-chasing, not decision-making.

The most common way dental acquisitions die has nothing to do with credit or DSCR — it's the calendar. Sellers, especially retiring dentists with a date circled, routinely push for 30–60 day closes. Brokers representing the practice encourage it, and competing buyers (particularly DSOs paying cash) can actually deliver it. SBA financing, even on a dental-specialized PLP desk running at full speed, needs 60–75 days — and 90–120 at a generalist lender. That gap is where good buyers lose good practices.

Three ways to survive the collision:

• Get underwritten before you offer. A buyer with a lender-issued term sheet, personal financials already verified, and a valuation firm on standby compresses the post-agreement timeline by 2–3 weeks and makes a 65-day close credible on paper. Start the SBA qualification process while you're still touring practices, not after you've signed a letter of intent.
• Negotiate timeline honestly, with proof. A term sheet from a PLP with a dental book, shown to the seller's broker, converts "SBA takes forever" from a dealbreaker into a scheduling detail. Sellers accept 70 days from a prepared buyer far more readily than 45 days from an unprepared one.
• Bridge the operating gap with working capital. Where the collision actually bites is cash: earnest money, valuation and legal fees, credentialing costs, and the first weeks of payroll and supplies after close all land before the practice's insurance reimbursements start flowing to the new owner — reimbursements that lag treatment by 30–90 days. A revenue-based working capital advance ($25K–$2M, funded in as little as 6 hours, repaid through a small fixed weekly debit over 3–18 months) covers that gap without touching the SBA structure — it's underwritten on bank deposits, not collateral, so it doesn't conflict with the acquisition lender's lien position when structured correctly. For the full playbook on how practices use short-cycle capital around the insurance lag, see our guide to working capital for dental practices.

This two-instrument structure — SBA loan for the purchase, working capital for the transition — is how experienced dental buyers actually close. Bay Street Lending runs both from one application: the acquisition file goes to dental-experienced SBA lenders among our 50+ funding partners, and if the timeline demands it, transition capital can be in the account the same week. One soft credit pull, no upfront fees, and offers on clean files typically inside 4 hours on the working capital side.